Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis

(2020) Tae-Kyung Yoo et al.   BREAST CANCER RESEARCH AND TREATMENT

Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy

(2020) Muayad F. Almahariq et al.   ANNALS OF SURGICAL ONCOLOGY

Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer

(2020) Mara A. Piltin et al.   ANNALS OF SURGICAL ONCOLOGY

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer

(2020) Stephanie M. Wong et al.   ANNALS OF SURGICAL ONCOLOGY

Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery

(2020) Stephanie Angarita et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

(2020) Sabrina Kahler-Ribeiro-Fontana et al.   EJSO

Diagnostic Performance of Noninvasive Imaging for Assessment of Axillary Response After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer

(2020) Sanaz Samiei et al.   ANNALS OF SURGERY

Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

(2019) Alison Laws et al.   ANNALS OF SURGICAL ONCOLOGY

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

(2018) Toan T. Nguyen et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result

(2018) Geok Hoon Lim et al.   EJSO

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial

(2018) Guido Henke et al.   Trials

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy

(2016) Judy C. Boughey et al.   ANNALS OF SURGERY

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

(2016) Anita Mamtani et al.   ANNALS OF SURGICAL ONCOLOGY

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

(2016) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?

(2015) Melissa Pilewskie et al.   ANNALS OF SURGICAL ONCOLOGY

Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapyversusaxillary node clearance in patients with operable node-positive breast cancer

(2015) A. U. Bing et al.   BRITISH JOURNAL OF SURGERY

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

(2015) Jean-Francois Boileau et al.   JOURNAL OF CLINICAL ONCOLOGY

Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

(2014) Elizabeth A. Mittendorf et al.   ANNALS OF SURGICAL ONCOLOGY

Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer

(2014) Abigail S. Caudle et al.   ANNALS OF SURGICAL ONCOLOGY

Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

(2014) Reshma Jagsi et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

(2013) Viviana Galimberti et al.   LANCET ONCOLOGY

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer

(2013) Tina J. Hieken et al.   SURGERY

A 10-Year Trend Analysis of Sentinel Lymph Node Frozen Section and Completion Axillary Dissection for Breast Cancer: Are These Procedures Becoming Obsolete?

(2011) Walter P. Weber et al.   ANNALS OF SURGICAL ONCOLOGY

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION